Lacerda, L;
Flynn, AO;
Pung, W;
Heavey, B;
Farid, Suzanne S;
(2024)
Reimagining the Future of Biopharmaceutical Digitalization.
BioProcess International
, 22
(9)
pp. 10-17.
Preview |
Text
Lacerda Accenture Farid ReimaginingBiopharmaDigi BPI24.pdf - Published Version Download (427kB) | Preview |
Abstract
The biopharmaceutical industry is increasingly adopting digitalization to enhance efficiency and product quality. Current systems like ELNs, LIMS, and MES often lack interoperability, driving vendors toward modular, standardized solutions, exemplified by initiatives like SiLA and the Allotrope framework. Digital twins and AI enable predictive analytics and in silico simulations, reducing costs and accelerating development timelines. However, challenges in technology transfer and data management persist. Organizations must foster collaboration among stakeholders, implement change management practices, and invest in training to overcome these hurdles. Ultimately, a digital strategy will improve connectivity and streamline processes, delivering better outcomes for patients.
| Type: | Article |
|---|---|
| Title: | Reimagining the Future of Biopharmaceutical Digitalization |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://www.bioprocessintl.com/information-technol... |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10206809 |
Archive Staff Only
 |
View Item |
